Clal Biotechnology Industries Ltd. (TLV:CBI)
Israel · Delayed Price · Currency is ILS · Price in ILA 25.70
0.00 (0.00%)
Sep 10, 2026, 11:27 AM IDT
TLV:CBI Market Cap
TLV:CBI has a market cap or net worth of 40.31 million as of September 11, 2026. Its market cap has decreased by -29.01% in one year.
Market Cap
40.31M
Enterprise Value
57.27M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
25.70
ChartMarket Cap Chart
Since July 23, 2007, TLV:CBI's market cap has decreased from 797.05M to 40.31M, a decrease of -94.94%. That is a compound annual growth rate of -14.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 40.31M | -15.46% |
| Dec 31, 2025 | 47.68M | -12.89% |
| Dec 31, 2024 | 54.74M | -12.09% |
| Dec 31, 2023 | 62.27M | -36.78% |
| Dec 29, 2022 | 98.50M | -46.87% |
| Dec 30, 2021 | 185.39M | -41.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bonus BioGroup | 202.09M |
| Matricelf | 80.79M |
| BioLineRx | 34.07M |
| BioLight Life Sciences | 26.35M |
| XTL Biopharmaceuticals | 25.16M |
| Evogene | 23.78M |
| Purple Biotech | 18.65M |
| Can-Fite BioPharma | 14.84M |